SCHEMBL6416053

SCHEMBL6416053

CC(C)(C)[Si](C)(C)O[C@H](CSc1nc2ccccc2s1)C1CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 4/20 0.46
▸ CYP2D6 P10635 4/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ CYP3A4 P08684 2/20 0.46
▸ CYP2C19 P33261 2/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ HIF1A Q16665 1/20 0.46
▸ ALDH1A1 P00352 8/20 0.46
▸ HPGD P15428 3/20 0.46
▸ APEX1 P27695 2/20 0.44
▸ SMN1; SMN2 Q16637 6/20 0.43
▸ HSD17B10 Q99714 5/20 0.43
▸ RAB9A P51151 4/20 0.43
▸ MAPT P10636 3/20 0.43
▸ NPC1 O15118 3/20 0.43
▸ HTR1A P08908 1/20 0.43
▸ HTR2A P28223 1/20 0.43
▸ HTR7 P34969 1/20 0.43
▸ CYP2C9 P11712 1/20 0.42
▸ STAT6 P42226 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6159705 0.81 CYP1A2 (0.52) CYP1A2CYP2D6L3MBTL1CYP3A4CYP2C19
SCHEMBL6415916 0.76 ALDH1A1 (0.44) CYP1A2L3MBTL1CYP2C19ALDH1A1SMN1; SMN2
SCHEMBL28996772 0.74 APEX1 (0.59) CYP1A2CYP2D6L3MBTL1CYP3A4CYP2C19
SCHEMBL28996770 0.74 APEX1 (0.59) CYP1A2CYP2D6L3MBTL1CYP3A4CYP2C19
SCHEMBL30429401 0.74 APEX1 (0.59) CYP1A2CYP2D6L3MBTL1CYP3A4CYP2C19
SCHEMBL28069624 0.72 ALDH1A1 (0.49) CYP1A2CYP2D6L3MBTL1CYP3A4CYP2C19
SCHEMBL10989220 0.71 CYP1A2 (0.67) CYP1A2CYP2D6L3MBTL1CYP3A4CYP2C19
SCHEMBL29023728 0.70 CYP1A2 (0.56) CYP1A2CYP2D6L3MBTL1CYP3A4CYP2C19
SCHEMBL10037466 0.69 APEX1 (0.64) CYP1A2CYP2D6L3MBTL1CYP3A4CYP2C19
SCHEMBL3022326 0.69 CYP1A2 (0.63) CYP1A2CYP2D6L3MBTL1CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050119241-A1 Preparation of 24 alkyl analogs of cholecalciferol and non-racemic compounds INSTYTUT FARMACEUTYCZNY (PL) 2005-06-02 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050119241-A1 Preparation of 24 alkyl analogs of cholecalciferol and non-racemic compounds CYP24A1, CYP2R1, VDR CYP1A2 159/4885CYP2D6 83/4885L3MBTL1 2615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback